Boston, MA 03/20/2014 (wallstreetpr) – A look at the short-term moment trend of the stock of Prothena Corporation PLC (NASDAQ:PRTA) and the earnings estimates revisions leaves no doubt that there is a lot that require attention. Thus, we dig deep to unearth the facts and figures that will enable you to make the best investment decision regarding this stock.
Shares of PRTA closed $47.39, up 27.53 percent in the last session. The sticker was active mover in the previous session where an exceeding number of shares changed hands than in a normal session. The Wednesday session saw the stock touching a new 52-week high at $47.49, having emerged from the low of $6.41 in the past year.
The biotech company not only boasts interesting short-term momentum, but also solid earnings estimate revision activity, all of which are important combination when trailing a stock.
Positive estimates revision
When earnings estimate revisions are seen to be increasingly positive, the clear and simple message is that analysts are getting more optimistic on a stock’s earning prospects. And that is what is happening in Prothena Corporation PLC (NASDAQ:PRTA) currently. The stock is witnessing not just increasingly positive estimates, but the consensus estimates are sharply higher on both the current quarter and fiscal year.
In the past four weeks, the stock has received one higher earnings estimate revision with no downward revision in the time frame for the current quarter. The earnings estimates on the stock have grown from a loss of $0.41 per share in the past 30 days to positive earnings of $0.81 per share currently. That suggests a significant move of 297.6 percent. So the trend on the stock has been pretty good looking at the percentage jumped.
As for the current fiscal year, the past four weeks has invited two higher estimates movement and no downward movement in the same time frame. The consensus earnings estimate thus stands currently at loss of $0.71 per share, up from loss of $1.96 per share in the past 30 days. This improvement signals more than 63 percent jump.
Investor takeaway
The uptrend in earnings estimates revisions and the positive momentum on the stock all go a long way to suggest that Prothena Corporation PLC (NASDAQ:PRTA) is an impressive story for investor who want more.
